ABSTRACT
Dermatology dogma has cautioned against the use of orally administered glucocorticoids (OAG) in the treatment of psoriasis, largely due to concerns of life-threatening generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). However, studies show that OAG are frequently used for psoriasis, often by dermatologists. Given the widespread use of OAG, we see an urgency in examining the relationship between OAG usage and the development of GPP and EP. This anonymous electronic survey of 50 US dermatologists examines OAG use in the management of psoriasis and the frequency at which dermatologists report seeing associated adverse outcomes of GPP and EP. Overall, 9 out of 50 (18%) respondents occasionally prescribe OAG to patients with psoriasis. Dermatologists who prescribe OAG tended to be younger than those who did not, with two-thirds in clinical practice for 0-10 years. Among all respondents, 16% (8/50) had experienced one or more patients developing GPP/EP in the context of OAG treatment for psoriasis. Our study suggests that OAG for the management of psoriasis is not uncommon among U.S. dermatologists, despite nearly universal awareness of its risks. Our observed low prevalence of GPP and EP emphasizes the need for prospective studies to better characterize OAG’s risk/benefit profile in psoriasis. J Drugs Dermatol. 2022;21(4):427-429. doi:10.36849/JDD.6242.
Subject(s)
Glucocorticoids , Psoriasis , Acute Disease , Dermatologists , Glucocorticoids/adverse effects , Humans , Prospective Studies , Psoriasis/epidemiology , Surveys and Questionnaires , United States/epidemiologyABSTRACT
We describe a rare case of a patient with mixed connective tissue disease maintained on chronic oral corticosteroids, who was hospitalized on five occasions over five consecutive months due to persistent relapsing neutrophilic meningitis caused by Nocardia asteroides. Immunosuppression due to the chronic use of corticosteroids was identified as the underlying mechanism of susceptibility. Our report highlights the challenges associated with systemic Nocardiosis, particularly in the immunocompromised host.
Subject(s)
Exophthalmos , Methylprednisolone/administration & dosage , Polychondritis, Relapsing/complications , Tomography, X-Ray Computed/methods , Administration, Intravenous , Aged , Exophthalmos/diagnostic imaging , Exophthalmos/drug therapy , Exophthalmos/etiology , Humans , Immunosuppressive Agents/administration & dosage , Male , Polychondritis, Relapsing/therapy , Treatment OutcomeABSTRACT
Practitioners of rheumatology in the 21st century are increasingly recognizing the benefits of computer technology as they relate to point-of-service care delivered in the hospital or in the outpatient setting. Electronic medical records and other computer-driven aids are resources emerging as affordable tools that can greatly enhance the rheumatologist's ability to provide stellar care, reduce professional and administrative burdens and improve lifestyle measures. Herein, we provide a practical nontechnical introduction to the world of electronic medical records, personal digital assistants, and other computer-dependent tools, with an emphasis placed on how these instruments can be used by the clinical rheumatologist to achieve excellence in medical care.
ABSTRACT
Bezoars are an uncommon cause of acute gastric outlet obstruction. To our knowledge, this is the first report of a bezoar formed around a gallstone that migrated to the stomach via a cholecystogastric fistula. Our patient was a 42-year-old African American woman with long-standing type 2 diabetes. We suspect that diabetic diathesis was the major factor responsible for producing the pathologic derangement of the gallbladder and stomach, which led to development of the bezoar and serious complications.